| Literature DB >> 15919818 |
Yoshikazu Masuhiro1, Yoshihiro Mezaki, Matomo Sakari, Ken-ichi Takeyama, Tasuku Yoshida, Kunio Inoue, Junn Yanagisawa, Shigemasa Hanazawa, Bert W O'malley, Shigeaki Kato.
Abstract
Mitogen-activated protein kinase-mediated growth factor signals are known to augment the ligand-induced transactivation function of nuclear estrogen receptor alpha (ERalpha) through phosphorylation of Ser-118 within the ERalpha N-terminal transactivation (activation function-1) domain. We identified the spliceosome component splicing factor (SF)3a p120 as a coactivator specific for human ERalpha (hERalpha) activation function-1 that physically associated with ERalpha dependent on the phosphorylation state of Ser-118. SF3a p120 potentiated hERalpha-mediated RNA splicing, and notably, the potentiation of RNA splicing by SF3a p120 depended on hER Ser-118 phosphorylation. Thus, our findings suggest a mechanism by which growth factor signaling can regulate gene expression through the modulation of RNA splicing efficiency via phosphorylation of sequence-specific activators, after association between such activators and the spliceosome.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15919818 PMCID: PMC1149443 DOI: 10.1073/pnas.0503197102
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205